Home/Protagenic Therapeutics/Alexander K. Arrow
AK

Alexander K. Arrow

Chief Financial Officer

Protagenic Therapeutics

Therapeutic Areas

Protagenic Therapeutics Pipeline

DrugIndicationPhase
PT00114Stress-related Neuropsychiatric Disorders (e.g., Depression, Anxiety, PTSD, Addiction)Phase 1
TCAP PlatformNeurodegenerative Diseases (e.g., Alzheimer's, Parkinson's)Preclinical